6/6/2014 9:06:09 AM
GAINESVILLE, Fla., June 5, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced that company management will present at two upcoming investor conferences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by